Wyeth
New York, NY, US· latest recorded location
Wyeth is named on 1,325 US grants and 2,040 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 1,325
- Published applications
- 2,040
- Inventors
- 2,240
- Granted in 2026 so far
- 0
- Most recent grant
- 20 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 0 | 4 |
| 2002 | 53 | 62 |
| 2003 | 82 | 171 |
| 2004 | 89 | 164 |
| 2005 | 64 | 226 |
| 2006 | 122 | 257 |
| 2007 | 128 | 264 |
| 2008 | 139 | 247 |
| 2009 | 166 | 210 |
| 2010 | 161 | 136 |
| 2011 | 65 | 64 |
| 2012 | 50 | 57 |
| 2013 | 51 | 42 |
| 2014 | 38 | 33 |
| 2015 | 31 | 25 |
| 2016 | 19 | 20 |
| 2017 | 20 | 18 |
| 2018 | 11 | 9 |
| 2019 | 14 | 9 |
| 2020 | 8 | 10 |
| 2021 | 8 | 1 |
| 2022 | 2 | 4 |
| 2023 | 0 | 5 |
| 2024 | 2 | 1 |
| 2025 | 2 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 3,365 documents
- A61PTherapeutic uses of medicines2,484
- C07DHeterocyclic compounds1,539
- A61KMedicines and medical preparations1,530
- C07KPeptides668
- C12NMicroorganisms or enzymes373
- C07CAcyclic or carbocyclic compounds274
- G01NInvestigating or analysing materials by determining their chemical or physical properties260
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms113
- A01KAnimal husbandry108
- Y02ATechnologies for adaptation to climate change88
Recent patents
- Formulations for parenteral delivery of compounds and uses thereof20 May 2025US 12,303,592 B2
- Pneumococcal dosing regimen18 Feb 2025US 12,226,470 B2
- Methods of protein production using anti-senescence compounds6 Aug 2024US 12,054,762 B2
- Multivalent pneumococcal polysaccharide-protein conjugate composition30 Apr 2024US 11,969,474 B2
- Compositions relating to a mutant clostridium difficile toxin and methods thereof27 Dec 2022US 11,535,652 B2
- Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof2 Apr 2026US 2026/0092046 A1
- Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition12 Dec 2024US 2024/0408221 A1
- Formulations for parenteral delivery of compounds and uses thereof28 Dec 2023US 2023/0414490 A1
- Compositions relating to a mutant clostridium difficile toxin and methods thereof7 Dec 2023US 2023/0391835 A1
- Use Of Perfusion To Enhance Production Of Fed-batch Cell Culture In Bioreactors16 Nov 2023US 2023/0365920 A1
Most cited
By later US patents
- Antibodies against PD-1450US 7,488,802 B22009
- 6-amino-1,4-dihydro-benzo[d][1,3] oxazin-2-ones and analogs useful as progesterone receptor modulators251US 7,247,625 B22007
- Neutralizing antibodies against GDF-8 and uses therefor196US 7,261,893 B22007
- Methods of upmodulating adaptive immune response using anti-PD-1 antibodies172US 7,521,051 B22009
- Methods for downmodulating immune cells using an antibody to PD-1171US 7,029,674 B22006